Corion Biotech develops innovative organic medicines derived from human placenta and aimed at therapeutic interventions for women's health. In particular, it is perfecting the world's first specific therapy against pre-eclampsia, a human pregnancy syndrome that affects about 7 million pregnant women every year and represents one of the main causes of maternal-fetal mortality worldwide.

Last update: 06/04/2021